Crinetics Pharmaceuticals Inc (CRNX) support and resistance · rev $35.9M
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
This page maps Crinetics Pharmaceuticals Inc (CRNX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
CRNX currently screens at market cap $2.76B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRNX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRNX quote page for the session range and the stock page for the full model.
Not investment advice.